C 19 H 14 BrFeN, monoclinic, P2 1 /c (no. 14), a =9.8612(3) Å, b =13.8034(5) Å, c =11.3372(5) Å, b =90.072(3)°,
Source of materialThetitle compound was prepared as described in literature [1]and recrystallized from dichloromethane/petroleum ether solution at room temperature to give the desired crystals suitable for singlecrystal X-raydiffraction.
DiscussionQuinolines are present in awide range of natural products with remarkable pharmacologicalp roperties [2][3]. In addition, ferrocenyl derivatives have found numeroususes in various fields of science from organic chemistry to biochemistry [4][5]. Although quinolines are among the most extensively studied heterocyclic compounds [6][7], ferrocenylquinolines are not often found in the literature [1,[8][9][10][11]. Here we report the crystal structure of acompound, obtained via a-alkylation of acetylferrocene and(2-amino-5-bromophenyl)methanol. Aview of the molecular structure of the title compound is given in the figure. The two cyclopentadienyl rings are almost parallel with adihedral angle of 2.7°.The substitutedcyclopentadienyland quinolinyl ring are approximately coplanar, making adihedral angle of 16.1°. In the crystal there exist intermolecular C-Br×××Nhalogen bonds (Br×××N =3.197 Å) [12],which are attributed to constructaone-dimensional chain structure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.